Essential anticancer medicines for children: defining what matters most for Europe
Lancet Oncol
.
2022 Dec;23(12):1479-1480.
doi: 10.1016/S1470-2045(22)00689-1.
Author
Avram Denburg
1
Affiliation
1
Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto M5G 1X8, ON, Canada. Electronic address: avram.denburg@sickkids.ca.
PMID:
36455569
DOI:
10.1016/S1470-2045(22)00689-1
No abstract available
Publication types
Comment
MeSH terms
Antineoplastic Agents* / therapeutic use
Child
Europe
Humans
Neoplasms* / drug therapy
Pediatrics*
Substances
Antineoplastic Agents